Oncogenic somatic events in tissue-specific stem cells: A role in cancer recurrence?

Ageing Research Reviews

Volumn 13, Issue 1, 2014, Pages 100-106

  Hartwig, F P ^a   Nedel, F ^a   Collares, T ^a   Tarquinio, S B C ^a   Nor J E ^b   Demarco, F F ^a  

^a FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Asymmetric division; Cancer recurrence; Niche protection; Somatic oncogenic event; Tissue specific stem cells

Indexed keywords

CANCER CELL; CANCER RECURRENCE; CANCER RESEARCH; CANCER RISK; CARCINOGENESIS; CLINICAL PRACTICE; DAUGHTER CELL; HOMEOSTASIS; HUMAN; MEDICAL RESEARCH; MUTATION; ONCOGENE; RECURRENCE RISK; REVIEW; SOMATIC MUTATION; STEM CELL; TISSUE SPECIFICITY;

ASYMMETRIC DIVISION; CANCER RECURRENCE; NICHE PROTECTION; SOMATIC ONCOGENIC EVENT; TISSUE-SPECIFIC STEM CELLS;

ANIMALS; CELL PROLIFERATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS; NEOPLASTIC STEM CELLS; ONCOGENES; PHENOTYPE; PROGNOSIS; RISK FACTORS; STEM CELL NICHE; TUMOR MICROENVIRONMENT;

EID: 84892554828     PISSN: 15681637     EISSN: 18729649     Source Type: Journal    
DOI: 10.1016/j.arr.2013.12.004     Document Type: Review

References (34)

1. Armanios M. Telomeres and age-related disease: how telomere biology informs clinical paradigms. J. Clin. Invest. 2013, 123:996-1002.
2. Armanios M., Blackburn E.H. The telomere syndromes. Nat. Rev. Genet. 2012, 13:693-704.
3. Borovski T., De Sousa E.M.F., Vermeulen L., Medema J.P. Cancer stem cell niche: the place to be. Cancer Res. 2011, 71:634-639.
4. Breault D.T., Min I.M., Carlone D.L., Farilla L.G., Ambruzs D.M., Henderson D.E., Algra S., Montgomery R.K., Wagers A.J., Hole N. Generation of mTert-GFP mice as a model to identify and study tissue progenitor cells. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:10420-10425.
5. de Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev. 2005, 19:2100-2110.
6. Deng Y., Chan S.S., Chang S. Telomere dysfunction and tumour suppression: the senescence connection. Nat. Rev. Cancer 2008, 8:450-458.
7. Donate L.E., Blasco M.A. Telomeres in cancer and ageing. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 2011, 366:76-84.
8. Feldser D.M., Hackett J.A., Greider C.W. Telomere dysfunction and the initiation of genome instability. Nat. Rev. Cancer 2003, 3:623-627.
9. Flores I., Benetti R., Blasco M.A. Telomerase regulation and stem cell behaviour. Curr. Opin. Cell Biol. 2006, 18:254-260.
10. Flores I., Blasco M.A. The role of telomeres and telomerase in stem cell aging. FEBS Lett. 2010, 584:3826-3830.
11. Flores I., Canela A., Vera E., Tejera A., Cotsarelis G., Blasco M.A. The longest telomeres: a general signature of adult stem cell compartments. Genes Dev. 2008, 22:654-667.
12. Fuchs E., Chen T. A matter of life and death: self-renewal in stem cells. EMBO Rep. 2013, 14:39-48.
13. Han Y.K., Lee J.H., Park G.Y., Chun S.H., Han J.Y., Kim S.D., Lee J., Lee C.W., Yang K., Lee C.G. A possible usage of a CDK4 inhibitor for breast cancer stem cell-targeted therapy. Biochem. Biophys. Res. Commun. 2013, 430:1329-1333.
14. Hartwig F.P., Collares T. Telomere dysfunction and tumor suppression responses in dyskeratosis congenita: balancing cancer and tissue renewal impairment. Ageing Res. Rev. 2013, 12:642-652.
15. Hartwig F.P., Nedel F., Collares T.V., Tarquinio S.B., Nor J.E., Demarco F.F. Telomeres and tissue engineering: the potential roles of TERT in VEGF-mediated angiogenesis. Stem Cell Rev. 2012, 8:1275-1281.
16. Hayashi S., McMahon A.P. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse. Dev. Biol. 2002, 244:305-318.
17. Helgason G.V., Young G.A., Holyoake T.L. Targeting chronic myeloid leukemia stem cells. Curr. Hematol. Malig. Rep. 2010, 5:81-87.
18. Jaskelioff M., Muller F.L., Paik J.H., Thomas E., Jiang S., Adams A.C., Sahin E., Kost-Alimova M., Protopopov A., Cadinanos J., Horner J.W., Maratos-Flier E., Depinho R.A. Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice. Nature 2011, 469:102-106.
19. Kirwan M., Dokal I. Dyskeratosis congenita, stem cells and telomeres. Biochim. Biophys. Acta 2009, 1792:371-379.
20. Leiros G.J., Balana M.E. Metastatic cancer stem cells: new molecular targets for cancer therapy. Curr. Pharm. Biotechnol. 2011, 12:1909-1922.
21. Li J., Wang L., Mamon H., Kulke M.H., Berbeco R., Makrigiorgos G.M. Replacing PCR with COLD-PCR enriches variant DNA sequences and redefines the sensitivity of genetic testing. Nat. Med. 2008, 14:579-584.
22. Mason P.J., Bessler M. The genetics of dyskeratosis congenita. Cancer Genet. 2011, 204:635-645.
23. Metcalfe C., de Sauvage F.J. A tumor-specific stem cell. Nat. Genet. 2013, 45:7-9.
24. Metzger D., Chambon P. Site- and time-specific gene targeting in the mouse. Methods 2001, 24:71-80.
25. Morrison S.J., Kimble J. Asymmetric and symmetric stem-cell divisions in development and cancer. Nature 2006, 441:1068-1074.
26. Morrison S.J., Spradling A.C. Stem cells and niches: mechanisms that promote stem cell maintenance throughout life. Cell 2008, 132:598-611.
27. Olovnikov A.M. A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J. Theor. Biol. 1973, 41:181-190.
28. Schuller U., Heine V.M., Mao J., Kho A.T., Dillon A.K., Han Y.G., Huillard E., Sun T., Ligon A.H., Qian Y., Ma Q., Alvarez-Buylla A., McMahon A.P., Rowitch D.H., Ligon K.L. Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form Shh-induced medulloblastoma. Cancer Cell 2008, 14:123-134.
29. Tarnok A., Ulrich H., Bocsi J. Phenotypes of stem cells from diverse origin. Cytometry A 2010, 77:6-10.
30. Visvader J.E. Cells of origin in cancer. Nature 2011, 469:314-322.
31. Vulliamy T.J., Knight S.W., Mason P.J., Dokal I. Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita. Blood Cells. Mol. Dis. 2001, 27:353-357.
32. Winkler I.G., Barbier V., Nowlan B., Jacobsen R.N., Forristal C.E., Patton J.T., Magnani J.L., Levesque J.P. Vascular niche E-selectin regulates hematopoietic stem cell dormancy, self-renewal and chemoresistance. Nat. Med. 2012, 18:1651-1657.
33. Yang Z.J., Ellis T., Markant S.L., Read T.A., Kessler J.D., Bourboulas M., Schuller U., Machold R., Fishell G., Rowitch D.H., Wainwright B.J., Wechsler-Reya R.J. Medulloblastoma can be initiated by deletion of patched in lineage-restricted progenitors or stem cells. Cancer Cell 2008, 14:135-145.
34. Youssef K.K., Van Keymeulen A., Lapouge G., Beck B., Michaux C., Achouri Y., Sotiropoulou P.A., Blanpain C. Identification of the cell lineage at the origin of basal cell carcinoma. Nat. Cell Biol. 2010, 12:299-305.